Interleukin-6-type cytokines upregulate expression of multidrug resistance-associated proteins in NHEK and dermal fibroblasts

Journal of Investigative Dermatology

Volumn 124, Issue 1, 2005, Pages 28-37

  Dreuw, Alexandra ^a   Hermanns, Heike M ^a   Heise, Ruth ^a   Joussen, Sylvia ^a   Rodríguez, Felipe ^a   Marquardt, Yvonne ^a   Jugert, Frank ^a   Merk, Hans F ^a   Heinrich, Peter C ^a   Baron, Jens M ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Efflux transporter; Inflammation; Lichen planus; Oncostatin M; Psoriasis

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; CYTOKINE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MULTIDRUG RESISTANCE PROTEIN; ONCOSTATIN M; PHOSPHATIDYLINOSITOL KINASE; STAT1 PROTEIN; STAT3 PROTEIN;

ARTICLE; ASSAY; DERMIS; DNA MICROARRAY; EPIDERMIS; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LICHEN PLANUS; PRIORITY JOURNAL; PSORIASIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN DEFECT; SKIN INFLAMMATION; UPREGULATION;

EID: 19944426746     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.23499.x     Document Type: Article

References (36)

1. Arcone R, Pucci P, Zappacosta F, Fontaine V, Malorni A, Marino G, Ciliberto G: Single-step purification and structural characterization of human interleukin-6 produced in Escherchia coli from a T7 RNA polymerase expression vector. Eur J Biochem 198:541-547, 1991
2. Baron JM, Höller D, Schiffer R, Frankenberg S, Neis M, Merk HF, Jugert F: Expression of multiple cytochrome P450 enzymes and MDR-associated transport proteins in human skin keratinocytes. J Invest Dermatol 116:541-548, 2001
3. Baron JM, Neis M, Höller D, Schiffer R, Zwadlo-Klarwasser G, Merk HF, Jugert F: Transporter proteins and xenobiotica metabolizing enzymes in skin cells. In: Ring J, Weidinger S, Darsow U (eds). Skin and Environmen - Perception and Protection. Proceedings Division of 10th European Academy of Dematology and Venerology. Bologna, Italy: Monduzzi Editore, 2002; p 455-461
4. Baron JM, Zwadlo-Klarwasser G, Jugert F, Hamann W, Rübben A, Mukhtar H, Merk HF: Cytochrome P450 1B1: A major P450 enzyme in human blood monocytes and macrophage subsets. Biochem Pharmacol 56:1105-1110, 1998
5. Bernard C, Merval R, Lebret M, et al: Oncostatin M induces interleukin-6 and cyclooxygenase-2 expression in human vascular smooth muscle cells: Synergy with interleukin-1beta. Circ Res 85:1124-1131, 1999
6. Bonifati C, Mussi A, D'Auria L, Carducci M, Trento E, Cordiali-Fei P, Ameglio F: Spontaneous release of leukemia inhibitory factor and oncostatin-M is increased in supernatants of short-term organ cultures from lesional psoriatic skin. Arch Dermatol Res 290:9-13, 1998
7. Boxman I, Lowik C, Aarden L, Ponec M: Modulation of IL-6 production and IL-1 activity by keratinocyte-fibroblast interaction. J Invest Dermatol 101: 316-324, 1993
8. Dean M, Rzhetsky A, Allikmets R: The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 11:1156-1166, 2001
9. Fayyazi A, Schweyer S, Soruri A, et al: T lymphocytes and altered keratinocytes express interferon-gamma and interleukin 6 in lichen planus. Arch Dermatol Res 291:485-490, 1999
10. Flens MJ, Zaman JR, van der Valk P, et al: Tissue distribution of the multidrug resistance protein. Am J Pathol 148:1237-1247, 1996
11. Grossman RM, Krueger J, Yourish D, et al: Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86:6367-6371, 1989
12. Hartmann G, Cheung AK, Piquette-Miller M: Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J Pharmacol Exp Ther 303:273-281, 2002
13. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F: Principles of interleukin (IL)-6-type cytokine signaling and its regulation. Biochem J 374:1-20, 2003
14. Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L: Interleukin-6-type cytokine signaling through the gp130/Jak/STAT pathway. Biochem J 334:297-314, 1998
15. Hermanns HM, Radtke S, Schaper F, Heinrich PC, Behrmann I: Non-redundant signal transduction of interleukin-6-type cytokines. The adapter protein Shc is specifically recruited to rhe oncostatin M receptor. J Biol Chem 275:40742-40748, 2000
16. Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM: The soluble interleukin 6 receptor: Mechanisms of production and implications in disease. FASEB J 15:43-58, 2001
17. Kizaki M, Ueno H, Yamazoe Y, et al: Mechanisms of retinoid resistance in leukemic cells: Possible role of cytochrome P450 and P-glycoprotein. Blood 87:725-733, 1996
18. Knuefermann C, Lu Y, Liu B, et al: HER2/PI-3K/Akt activation leads to a mulitdrug resistance in human breast adenocarcinoma cells. Oncogene 22: 3205-3212, 2003
19. König J, Nies AT, Cui Y, Leier I, Keppler D: Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1461: 377-394, 1999
20. Kool M, de Haas M, Scheffer GL, et al: Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res 57:3537-3547, 1997
21. Kruh GD, Belinsky MG: The MRP family of drug efflux pumps. Oncogene 22:7537-7552, 2003
22. Kuo MT, Liu Z, Wei Y, Yen-chiu LL, Tatebe S, Mills GB, Unate H: Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-κB signaling. Oncogene 21:1945-1954, 2002
23. 30-latex. Nucl Acids Res Symp Ser 19:61-64, 1988
24. Lee G, Piquette-Miller M: Influence of IL-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells. Can J Physiol Pharmacol 79: 876-884, 2001
25. Loe DW, Deeley RG, Cole SP: Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): Evidence for cotransport with reduced glutathione. Cancer Res 58:5130-5136, 1998
26. Pfaff MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:2002-2007, 2001
27. Rappa G, Lorico A, Flavell RA, Sartorelli AC: Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res 57:5232-5237, 1997
28. Reid G, Wielinga R Zelcer N, et al: The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci USA 100: 9244-9249, 2003
29. Repovic P, Mi K, Benveniste EN: Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: Synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide. Glia 42:433-446, 2003
30. Schiemann WP, Bartoe JL, Nathanson NM: Box 3-independent signaling mechanisms are involved in leukemia inhibitory factor receptor alpha-and gp130-mediated stimulation of mitogen-activated protein kinase. Evidence for participation of multiple signaling pathways which converge at Ras. J Biol Chem 272:16631-16636, 1997
31. Schiffer R, Neis M, Holler D, et al: Active influx transport is mediated by members of the organic anion transporting polypeptide family in human epidermal keratinocytes. J Invest Dermatol 120:285-291, 2003
32. Sehgal PB: Interleukin-6: Molecular pathophysiology. J Invest Dermatol 94:2S-6S, 1990
33. Sukhai M, Piquette-Miller M: Regulation of the multidrug resistance genes by stress signals. J Pharm Pharmaceut Sci 3:268-280, 2000
34. Weiergräber O, Hemmann U, Küster A, et al: Soluble human interleukin-6 receptor. Expression in insect cells, purification and characterization. Eur J Biochem 234:661-669, 1995
35. Wijnholds J, Evers R, van Leusden MR, et al: Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat Med 3:1275-1279, 1997
36. Yabuuchi H, Takayanagi S, Yoshinaga K, Taniguchi N, Aburatani H, Ishikawa T: ABCC13, an unusual truncated ABC transporter, is highly expressed in fetal human liver. Biochem Biophys Res Commun 299:410-417, 2002